Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Lexeo Therapeutics, Inc. | 2,567,100 | reported | 07 Nov 2023 | tx 5+2,567,100−21,906,147 |
| Vera Therapeutics, Inc. | 1,714,285 | reported | 06 Feb 2023 | tx 4+4,810,879−2,187,504 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 07 Nov 2023 | PURCHASE | Lexeo Therapeutics, Inc. | 454,545 | 11.00 USD | |
| 07 Nov 2023 | CONVERSION | Lexeo Therapeutics, Inc. | 319,126 | — | |
| 07 Nov 2023 | CONVERSION | Lexeo Therapeutics, Inc. | 1,793,429 | — | |
| 07 Nov 2023 | CONVERSION | Lexeo Therapeutics, Inc. | 18,999,999 | — | deriv |
| 07 Nov 2023 | CONVERSION | Lexeo Therapeutics, Inc. | 2,906,148 | — | deriv |
| 06 Feb 2023 | PURCHASE | Vera Therapeutics, Inc. | 1,714,285 | 7.00 USD | first after silence |
| 18 May 2021 | CONVERSION | Vera Therapeutics, Inc. | 2,187,504 | — | |
| 18 May 2021 | PURCHASE | Vera Therapeutics, Inc. | 909,090 | 11.00 USD | |
| 18 May 2021 | CONVERSION | Vera Therapeutics, Inc. | 2,187,504 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 06 Feb 2023.